Date Issued
|
Report Number
16-01077-255
No. 1
to Veterans Health Administration (VHA)
Closure Date: 3/8/2018
We recommended that the Facility Director develop processes to ensure that the relevant providers complete timely patient evaluations for continued long-term opioid therapy for pain based on clinically significant changes or findings to a patient’s health status.
No. 2
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that reviews of the cases of the identified patients with clinically significant changes are completed and take action as appropriate.
No. 3
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that the relevant providers receive education on the concurrent prescribing of dual short acting opioids and tapering of opioids.
No. 4
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that the relevant providers review Veterans Health Administration recommendations regarding the use of opioid risk stratification tools, such as the Opioid Risk Tool, to identify high-risk patients for longterm opioid therapy for pain.
No. 5
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that the relevant providers order urine drug screening frequency based on risk assessment and complete urine drug screening at least annually.
No. 6
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that the relevant providers consistently use urine drug screening confirmatory testing.
No. 7
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director develop processes that minimize the potential for urine drug screening tampering.
No. 8
to Veterans Health Administration (VHA)
Closure Date: 1/11/2018
We recommended that the Facility Director ensure that the relevant providers consistently complete the informed consent process prior to initiating long-term opioid therapy for pain as specified by Veterans Health Administration policy.